Truvada
NDC Package 53808-0805-1
Package Information
Truvada is ®, a combination of EMTRIVA® and VIREAD®, is indicated in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults.The following points should be considered when initiating therapy with TRUVADA for the treatment of HIV-1 infection:It is not recommended that TRUVADA be used as a component of a triple nucleoside regimen.TRUVADA should not be coadministered with ATRIPLA®, EMTRIVA, VIREAD or lamivudine-containing products [See Warnings and Precautions (5.4)].In treatment experienced patients, the use of TRUVADA should be guided by laboratory testing and treatment history [See Clinical Pharmacology (12.4)]. Marketed by State Of Florida Doh Central Pharmacy, this product is identified by NDC 53808-0805 and is authorized under FDA application NDA021752.
Identification & Billing
- RxCUI: 476556 - emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
- RxCUI: 476556 - emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet
- RxCUI: 639888 - Truvada 200 MG / 300 MG Oral Tablet
- RxCUI: 639888 - emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Truvada]
- RxCUI: 639888 - Truvada (emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53808 - State Of Florida Doh Central Pharmacy
- 53808-0805 - Truvada
- 53808-0805-1 - 30 TABLET, FILM COATED in 1 BLISTER PACK
- 53808-0805 - Truvada
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53808-0805-1 identifies a specific commercial package of 30 tablet, film coated in 1 blister pack of Truvada, labeled by State Of Florida Doh Central Pharmacy. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by State Of Florida Doh Central Pharmacy on July 01, 2009. The current certification is valid through December 31, 2018.
How is this State Of Florida Doh Central Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53808080501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.